Israeli Pharmaceuticals & Biotech Potentially Undervalued Companies

Compugen

Market Cap: ₪216.5m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Enlivex

Market Cap: ₪221.5m

Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.

Teva Pharmaceutical Industries

Market Cap: ₪35.5b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Kamada

Market Cap: ₪1.5b

Manufactures and sells plasma-derived protein therapeutics.